Attached files
file | filename |
---|---|
10-K - FORM 10-K - DUSA PHARMACEUTICALS INC | y83067e10vk.htm |
EX-99.1 - EX-99.1 - DUSA PHARMACEUTICALS INC | y83067exv99w1.htm |
EX-21.A - EX-21.A - DUSA PHARMACEUTICALS INC | y83067exv21wa.htm |
EX-32.A - EX-32.A - DUSA PHARMACEUTICALS INC | y83067exv32wa.htm |
EX-32.B - EX-32.B - DUSA PHARMACEUTICALS INC | y83067exv32wb.htm |
EX-23.A - EX-23.A - DUSA PHARMACEUTICALS INC | y83067exv23wa.htm |
EX-31.A - EX-31.A - DUSA PHARMACEUTICALS INC | y83067exv31wa.htm |
EXHIBIT 31(b)
DUSA PHARMACEUTICALS, INC.
CERTIFICATIONS
I, Richard C. Christopher, certify that:
1. I have reviewed this annual report on Form 10-K of DUSA Pharmaceuticals,
Inc.;
2. Based on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of,
and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiary, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most
recent fiscal quarter (the registrants fourth fiscal quarter in the case of an
annual report) that materially affected, or is reasonably likely to materially
affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of directors
(or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrants ability to record, process, summarize
and report financial information; and
b) Any fraud, whether or not material, that involves management or
other employees who have a significant b role in the registrants internal
control over financial reporting.
Dated: March 4, 2010 | /s/ Richard C. Christopher | |||
Richard C. Christopher | ||||
Vice President, Finance and Chief Financial Officer (principal financial officer) |